NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 4,000 shares, a decline of 68.5% from the September 15th total of 12,700 shares. Based on an average daily volume of 24,300 shares, the short-interest ratio is currently 0.2 days.
NovAccess Global Stock Performance
OTCMKTS:XSNX traded down $0.02 during mid-day trading on Wednesday, hitting $0.12. 242 shares of the company traded hands, compared to its average volume of 7,029. The stock's fifty day moving average price is $0.18 and its 200-day moving average price is $0.24. NovAccess Global has a one year low of $0.10 and a one year high of $0.75.
Get NovAccess Global alerts:NovAccess Global Company Profile
(Get Rating)
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.Read More
- Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
- Put Pep In Your Portfolio With Low-Beta Pepsico
- Apple's Price Targets Are Changing
- Institutional Investors Are Buying These Two Stocks
- Is Take-Two Interactive Software Inc. a Q4 Winner?
- Why All the Buzz Around These 3 Stocks?
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.